Skip to main content
Erschienen in: Intensive Care Medicine 7/2015

01.07.2015 | Systematic Review

Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis

verfasst von: Sigrid Beitland, Irene Sandven, Lill-Kristin Kjærvik, Per Morten Sandset, Kjetil Sunde, Torsten Eken

Erschienen in: Intensive Care Medicine | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare benefits and harms of low molecular weight heparin (LMWH) versus unfractionated heparin (UFH) as thromboprophylaxis in intensive care unit (ICU) patients.

Methods

We conducted a systematic review with meta-analysis and trial sequential analysis (TSA) of randomised controlled trials (RCTs) comparing LMWH with UFH as thromboprophylaxis in adult ICU patients. We searched Ovid Medline, PubMed, Embase, Cochrane Library, UpToDate, Guidelines International Network, PROSPERO and the metaRegister of Controlled Trials through 3 December 2014. Random effects risk ratios (RR) and 95 % confidence intervals (CI) were derived for the endpoints deep vein thrombosis (DVT), pulmonary embolism (PE), major bleeding, mortality and net clinical benefit (any DVT, any PE, major bleeding and/or mortality).

Results

Eight RCTs (5567 patients) were included, whereof two were considered to have overall low risk of bias. Pooled analyses showed that LMWH compared with UFH reduced the risk of any DVT (RR 0.84, 95 % CI 0.71–0.98, p = 0.03) and resulted in a net clinical benefit (RR 0.90, 95 % CI 0.83–0.97, p = 0.01). There was no statistically significant difference in the risk of any PE (RR 0.65, 95 % CI 0.41–1.03, p = 0.06), major bleeding (RR 0.99, 95 % CI 0.77–1.28, p = 0.96) or mortality (RR 0.93, 95 % CI 0.78–1.12, p = 0.43). TSA supported the results of the conventional analysis on the outcome net clinical benefit but not on risk of any DVT.

Conclusions

Evidence from this systematic review revealed a beneficial effect of LMWH compared with UFH when used as thromboprophylaxis in ICU patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33:1565–1571PubMedCrossRef Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33:1565–1571PubMedCrossRef
2.
Zurück zum Zitat Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S–400SPubMedCrossRef Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S–400SPubMedCrossRef
3.
Zurück zum Zitat Ribic C, Lim W, Cook D et al (2009) Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review. J Crit Care 24:197–205PubMedCrossRef Ribic C, Lim W, Cook D et al (2009) Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review. J Crit Care 24:197–205PubMedCrossRef
4.
Zurück zum Zitat Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133:381S–453SPubMedCrossRef Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133:381S–453SPubMedCrossRef
5.
Zurück zum Zitat Guyatt GH, Akl EA, Crowther M et al (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):7S–47SPubMedCentralPubMedCrossRef Guyatt GH, Akl EA, Crowther M et al (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):7S–47SPubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Alhazzani W, Lim W, Jaeschke RZ et al (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:2088–2098PubMedCrossRef Alhazzani W, Lim W, Jaeschke RZ et al (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:2088–2098PubMedCrossRef
7.
Zurück zum Zitat Dentali F, Douketis JD, Gianni M et al (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 146:278–288PubMedCrossRef Dentali F, Douketis JD, Gianni M et al (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 146:278–288PubMedCrossRef
8.
Zurück zum Zitat Mismetti P, Laporte S, Darmon JY et al (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88:913–930PubMedCrossRef Mismetti P, Laporte S, Darmon JY et al (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88:913–930PubMedCrossRef
9.
Zurück zum Zitat Barrera LM, Perel P, Ker K et al (2013) Thromboprophylaxis for trauma patients. Cochrane Database Syst Rev 3:1–79 Barrera LM, Perel P, Ker K et al (2013) Thromboprophylaxis for trauma patients. Cochrane Database Syst Rev 3:1–79
10.
Zurück zum Zitat Kakkos SK, Caprini JA, Geroulakos G et al (2008) Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 4:1–37 Kakkos SK, Caprini JA, Geroulakos G et al (2008) Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 4:1–37
11.
Zurück zum Zitat Arnold DM, Donahoe L, Clarke FJ et al (2007) Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med 30:E93–102PubMed Arnold DM, Donahoe L, Clarke FJ et al (2007) Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med 30:E93–102PubMed
12.
Zurück zum Zitat Briegel J, Mohnle P (2013) International guidelines of the Surviving Sepsis Campaign: update 2012. Anaesthesist 62:304–309PubMedCrossRef Briegel J, Mohnle P (2013) International guidelines of the Surviving Sepsis Campaign: update 2012. Anaesthesist 62:304–309PubMedCrossRef
13.
Zurück zum Zitat Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928PubMedCentralPubMedCrossRef Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef
15.
Zurück zum Zitat Cohran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129CrossRef Cohran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129CrossRef
17.
Zurück zum Zitat Peduzzi P, Concato J, Kemper E et al (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379PubMedCrossRef Peduzzi P, Concato J, Kemper E et al (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379PubMedCrossRef
19.
Zurück zum Zitat Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002PubMedCrossRef Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002PubMedCrossRef
20.
Zurück zum Zitat Pogue JM, Yusuf S (1997) Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials 18:580–593PubMedCrossRef Pogue JM, Yusuf S (1997) Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials 18:580–593PubMedCrossRef
21.
Zurück zum Zitat Pogue J, Yusuf S (1998) Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 351:47–52PubMedCrossRef Pogue J, Yusuf S (1998) Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 351:47–52PubMedCrossRef
22.
Zurück zum Zitat Wetterslev J, Thorlund K, Brok J et al (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:64–75PubMedCrossRef Wetterslev J, Thorlund K, Brok J et al (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:64–75PubMedCrossRef
23.
Zurück zum Zitat Greenland S, Robins JM (1985) Estimation of a common effect parameter from sparse follow-up data. Biometrics 41:55–68PubMedCrossRef Greenland S, Robins JM (1985) Estimation of a common effect parameter from sparse follow-up data. Biometrics 41:55–68PubMedCrossRef
25.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006–1012PubMedCrossRef Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006–1012PubMedCrossRef
26.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–34PubMedCrossRef Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–34PubMedCrossRef
27.
Zurück zum Zitat Cohn SA, Moller BA, Feinstein AJ et al (1999) Prospective trial of low-molecular-weight heparin versus unfractionated heparin in moderately injured patients. Vasc Surg 33:219–223CrossRef Cohn SA, Moller BA, Feinstein AJ et al (1999) Prospective trial of low-molecular-weight heparin versus unfractionated heparin in moderately injured patients. Vasc Surg 33:219–223CrossRef
28.
Zurück zum Zitat Cook D, Meade M, Guyatt G et al (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364:1305–1314PubMedCrossRef Cook D, Meade M, Guyatt G et al (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364:1305–1314PubMedCrossRef
29.
Zurück zum Zitat De A, Roy P, Garg VK et al (2010) Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis 21:57–61PubMedCrossRef De A, Roy P, Garg VK et al (2010) Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis 21:57–61PubMedCrossRef
30.
Zurück zum Zitat Geerts WH, Jay RM, Code KI et al (1996) A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701–707PubMedCrossRef Geerts WH, Jay RM, Code KI et al (1996) A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701–707PubMedCrossRef
31.
Zurück zum Zitat Goldhaber S, Kett D, Cusumano CJ et al (2000) Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: a randomized controlled trial. J Am Coll Cardiol 35(Suppl):A325 Goldhaber S, Kett D, Cusumano CJ et al (2000) Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: a randomized controlled trial. J Am Coll Cardiol 35(Suppl):A325
32.
Zurück zum Zitat Greenfield LJ, Proctor MC, Rodriguez JL et al (1997) Posttrauma thromboembolism prophylaxis. J Trauma 42:100–103PubMedCrossRef Greenfield LJ, Proctor MC, Rodriguez JL et al (1997) Posttrauma thromboembolism prophylaxis. J Trauma 42:100–103PubMedCrossRef
33.
Zurück zum Zitat Roque T, Thompson J, Kuru T (2005) A clinical trial to compare thromboprophylaxis options in the medical ICU: challanges to treatment (conference abstract). Chest 128:296CrossRef Roque T, Thompson J, Kuru T (2005) A clinical trial to compare thromboprophylaxis options in the medical ICU: challanges to treatment (conference abstract). Chest 128:296CrossRef
34.
Zurück zum Zitat Shorr AF, Williams MD (2009) Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost 101:139–144PubMed Shorr AF, Williams MD (2009) Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost 101:139–144PubMed
35.
Zurück zum Zitat Baker SP, O’Neill B, Haddon W Jr et al (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14:187–196PubMedCrossRef Baker SP, O’Neill B, Haddon W Jr et al (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14:187–196PubMedCrossRef
37.
Zurück zum Zitat Marik PE, Andrews L, Maini B (1997) The incidence of deep venous thrombosis in ICU patients. Chest 111:661–664PubMedCrossRef Marik PE, Andrews L, Maini B (1997) The incidence of deep venous thrombosis in ICU patients. Chest 111:661–664PubMedCrossRef
38.
Zurück zum Zitat Hirsch DR, Ingenito EP, Goldhaber SZ (1995) Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 274:335–337PubMedCrossRef Hirsch DR, Ingenito EP, Goldhaber SZ (1995) Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 274:335–337PubMedCrossRef
39.
Zurück zum Zitat Harris LM, Curl GR, Booth FV et al (1997) Screening for asymptomatic deep vein thrombosis in surgical intensive care patients. J Vasc Surg 26:764–769PubMedCrossRef Harris LM, Curl GR, Booth FV et al (1997) Screening for asymptomatic deep vein thrombosis in surgical intensive care patients. J Vasc Surg 26:764–769PubMedCrossRef
40.
Zurück zum Zitat Twigg SJ, McCrirrick A, Sanderson PM (2001) A comparison of post mortem findings with post hoc estimated clinical diagnoses of patients who die in a United Kingdom intensive care unit. Intensive Care Med 27:706–710PubMedCrossRef Twigg SJ, McCrirrick A, Sanderson PM (2001) A comparison of post mortem findings with post hoc estimated clinical diagnoses of patients who die in a United Kingdom intensive care unit. Intensive Care Med 27:706–710PubMedCrossRef
41.
Zurück zum Zitat Wahl WL, Ahrns KS, Zajkowski PJ et al (2003) Normal d-dimer levels do not exclude thrombotic complications in trauma patients. Surgery 134:529–532PubMedCrossRef Wahl WL, Ahrns KS, Zajkowski PJ et al (2003) Normal d-dimer levels do not exclude thrombotic complications in trauma patients. Surgery 134:529–532PubMedCrossRef
42.
Zurück zum Zitat Cook DJ, Donadini MP (2010) Pulmonary embolism in medical-surgical critically ill patients. Hematol Oncol Clin North Am 24:677–688PubMedCrossRef Cook DJ, Donadini MP (2010) Pulmonary embolism in medical-surgical critically ill patients. Hematol Oncol Clin North Am 24:677–688PubMedCrossRef
43.
Zurück zum Zitat Cook D, Meade M, Guyatt G et al (2004) Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists. Crit Care 8:R145–R152PubMedCentralPubMedCrossRef Cook D, Meade M, Guyatt G et al (2004) Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists. Crit Care 8:R145–R152PubMedCentralPubMedCrossRef
44.
Zurück zum Zitat Hinz P, Lubenow N, Wessel A et al (2009) Thrombosis prophylaxis in trauma surgery units in Germany: a survey. Unfallchirurg 112:1029–1033PubMedCrossRef Hinz P, Lubenow N, Wessel A et al (2009) Thrombosis prophylaxis in trauma surgery units in Germany: a survey. Unfallchirurg 112:1029–1033PubMedCrossRef
45.
Zurück zum Zitat Junqueira DR, Perini E, Penholati RR et al (2012) Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 9:1–35 Junqueira DR, Perini E, Penholati RR et al (2012) Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 9:1–35
46.
Zurück zum Zitat Fareed J, Jeske W, Fareed D et al (2008) Are all low molecular weight heparins equivalent in the management of venous thromboembolism? Clin Appl Thromb Hemost 14:385–392PubMedCrossRef Fareed J, Jeske W, Fareed D et al (2008) Are all low molecular weight heparins equivalent in the management of venous thromboembolism? Clin Appl Thromb Hemost 14:385–392PubMedCrossRef
47.
Zurück zum Zitat Nenci GG (2003) Low molecular weight heparins: are they interchangeable? No. J Thromb Haemost 1:12–13PubMedCrossRef Nenci GG (2003) Low molecular weight heparins: are they interchangeable? No. J Thromb Haemost 1:12–13PubMedCrossRef
48.
Zurück zum Zitat Prandoni P (2003) Low molecular weight heparins: are they interchangeable? Yes. J Thromb Haemost 1:10–11PubMedCrossRef Prandoni P (2003) Low molecular weight heparins: are they interchangeable? Yes. J Thromb Haemost 1:10–11PubMedCrossRef
49.
Zurück zum Zitat van der Heijden JF, Prins MH, Buller HR (2000) Low-molecular-weight heparins: are they interchangeable? Haemostasis 30(Suppl 2):148–157PubMed van der Heijden JF, Prins MH, Buller HR (2000) Low-molecular-weight heparins: are they interchangeable? Haemostasis 30(Suppl 2):148–157PubMed
50.
Zurück zum Zitat Limpus A, Chaboyer W, McDonald E et al (2006) Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care 15:402–410PubMed Limpus A, Chaboyer W, McDonald E et al (2006) Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care 15:402–410PubMed
51.
Zurück zum Zitat Huo MH, Muntz J (2009) Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Clin Ther 31:1129–1141PubMedCrossRef Huo MH, Muntz J (2009) Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Clin Ther 31:1129–1141PubMedCrossRef
52.
Zurück zum Zitat Garcia-Olivares P, Guerrero JE, Galdos P et al (2014) PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain. Intensive Care Med 40:1698–1708PubMedCrossRef Garcia-Olivares P, Guerrero JE, Galdos P et al (2014) PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain. Intensive Care Med 40:1698–1708PubMedCrossRef
53.
Zurück zum Zitat Schaden E, Metnitz PG, Pfanner G et al (2012) Coagulation day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care. Intensive Care Med 38:984–990PubMedCrossRef Schaden E, Metnitz PG, Pfanner G et al (2012) Coagulation day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care. Intensive Care Med 38:984–990PubMedCrossRef
54.
Zurück zum Zitat Wilbur K, Lynd LD, Sadatsafavi M (2011) Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients—a pharmacoeconomic analysis. Clin Appl Thromb Hemost 17:454–465PubMedCrossRef Wilbur K, Lynd LD, Sadatsafavi M (2011) Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients—a pharmacoeconomic analysis. Clin Appl Thromb Hemost 17:454–465PubMedCrossRef
55.
Zurück zum Zitat Fowler RA, Mittmann N, Geerts W et al (2014) Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA 312:2135–2145PubMedCrossRef Fowler RA, Mittmann N, Geerts W et al (2014) Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA 312:2135–2145PubMedCrossRef
56.
Zurück zum Zitat Thorlund K, Imberger G, Walsh M et al (2011) The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis—a simulation study. PLoS One 6:e25491PubMedCentralPubMedCrossRef Thorlund K, Imberger G, Walsh M et al (2011) The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis—a simulation study. PLoS One 6:e25491PubMedCentralPubMedCrossRef
57.
Zurück zum Zitat Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines 6. Rating the quality of evidence—imprecision. J Clin Epidemiol 64:1283–1293PubMedCrossRef Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines 6. Rating the quality of evidence—imprecision. J Clin Epidemiol 64:1283–1293PubMedCrossRef
58.
Zurück zum Zitat Schulz KF, Chalmers I, Hayes RJ et al (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1(273):408–412CrossRef Schulz KF, Chalmers I, Hayes RJ et al (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1(273):408–412CrossRef
59.
Zurück zum Zitat Oxman AD, Guyatt GH (1992) A consumer’s guide to subgroup analyses. Ann Intern Med 16:78–84CrossRef Oxman AD, Guyatt GH (1992) A consumer’s guide to subgroup analyses. Ann Intern Med 16:78–84CrossRef
60.
Zurück zum Zitat Sun X, Briel M, Walter SD et al (2010) Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 30(340):c11 Sun X, Briel M, Walter SD et al (2010) Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 30(340):c11
61.
Zurück zum Zitat Egger M, Juni P, Bartlett C et al (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 7:1–76PubMed Egger M, Juni P, Bartlett C et al (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 7:1–76PubMed
62.
Zurück zum Zitat Egger M, Smith GD, Altman DG (1995) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ, London Egger M, Smith GD, Altman DG (1995) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ, London
63.
Zurück zum Zitat Raskob GE, Hirsh J (2003) Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest 124(Suppl 6):379S–385SPubMedCrossRef Raskob GE, Hirsh J (2003) Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest 124(Suppl 6):379S–385SPubMedCrossRef
64.
Zurück zum Zitat Tribout B, Colin-Mercier F (2007) New versus established drugs in venous thromboprophylaxis: efficacy and safety considerations related to timing of administration. Am J Cardiovasc Drugs 7:1–15PubMedCrossRef Tribout B, Colin-Mercier F (2007) New versus established drugs in venous thromboprophylaxis: efficacy and safety considerations related to timing of administration. Am J Cardiovasc Drugs 7:1–15PubMedCrossRef
65.
Zurück zum Zitat Bottaro FJ, Elizondo MC, Doti C et al (2008) Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis. Thromb Haemost 99:1104–1111PubMed Bottaro FJ, Elizondo MC, Doti C et al (2008) Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis. Thromb Haemost 99:1104–1111PubMed
66.
Zurück zum Zitat Skeik N, Rumery KK, Rodriguez GT (2014) The new era of anticoagulation. Ann Vasc Surg 28:503–514PubMedCrossRef Skeik N, Rumery KK, Rodriguez GT (2014) The new era of anticoagulation. Ann Vasc Surg 28:503–514PubMedCrossRef
67.
Zurück zum Zitat Cheng SS, Nordenholz K, Matero D et al (2012) Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition. Intensive Care Med 38:642–648PubMedCrossRef Cheng SS, Nordenholz K, Matero D et al (2012) Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition. Intensive Care Med 38:642–648PubMedCrossRef
68.
Zurück zum Zitat Malinoski D, Jafari F, Ewing T et al (2010) Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma 68:874–880PubMedCrossRef Malinoski D, Jafari F, Ewing T et al (2010) Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma 68:874–880PubMedCrossRef
69.
Zurück zum Zitat Robinson S, Zincuk A, Strom T et al (2010) Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care 14:R41PubMedCentralPubMedCrossRef Robinson S, Zincuk A, Strom T et al (2010) Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care 14:R41PubMedCentralPubMedCrossRef
Metadaten
Titel
Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis
verfasst von
Sigrid Beitland
Irene Sandven
Lill-Kristin Kjærvik
Per Morten Sandset
Kjetil Sunde
Torsten Eken
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 7/2015
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-3840-z

Weitere Artikel der Ausgabe 7/2015

Intensive Care Medicine 7/2015 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.